Table 1.
Subtype | Clinical features | MRI | Angiogram | Biopsy |
---|---|---|---|---|
Angiogram
-negative biopsy-positive |
cognitive impairment, greater CSF abnormalities, favourable response to treatment | meningeal and parenchymal enhancing lesions on MRI |
negative | granulomatous pattern |
Amyloid-β-
related cerebral angiitis (ABRA) |
older age, predominantly males, cognitive impairment | contrast-enhanced meningeal lesions |
positive | granulomatous pattern with β- amyloid deposition in vessel walls |
Meningeal enhancement in MRI | predominantly males, cognitive impairment, rapid response to treatment | prominent leptomeningeal enhancement |
negative | granulomatous pattern |
Spinal cord
involvement |
spinal cord symptoms, cerebral manifestations usually present | enhanced spinal (especially thoracic) lesions |
negative | necrotizing pattern |
Intracranial
or subarachnoid haemorrhage |
predominantly women, favourable response to treatment | intracranial or subarachnoid haemorrhage |
positive | necrotizing pattern |
Rapidly progressive | aggressive disease course, less responsive to treatment, often fatal outcome | bilateral, multiple, vessel lesions and infarctions |
positive | granulomatous or necrotizing pattern |
Classification according to Giannini and colleagues, 2012.4 Clinical and diagnostic features can overlap among disease subtypes.
CSF, cerebrospinal fluid; MRI, magnetic resonance imaging; PACNS, primary angiitis of the central nervous system